Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes

In Vivo

Volumn 19, Issue 6, 2005, Pages 979-982

  Panani, Anna D ^a   Pappa, Vasiliki ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromosome 8 aberrations; Conventional cytogenetics; Fluorescence in situ hybridization; Myelodysplastic syndrome

Indexed keywords

CELL DNA;

ADULT; ARTICLE; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KARYOTYPE; METAPHASE; MYELODYSPLASTIC SYNDROME;

EID: 27744593551     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189-199, 1982.
2. Mufti GJ: Pathobiology, classification and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 17: 543-557, 2004.
3. Chen Z and Sandberg AA: Molecular cytogenetics aspects of hematological malignancies: clinical implications. Am J Med Genet (Semin Med Genet) 115: 130-141, 2002.
4. Olney HJ and Le Beau MM: The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol 14: 479-495, 2001.
5. Mhawech P and Saleem A: Myelodysplastic syndrome: review of the cytogenetic and molecular data. Crit Rev Oncol Hematol 40: 229-238, 2001.
6. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohashiki K, Toyama K, Aul C, Mufti G and Benett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088, 1997.
7. Pfeilstoker M, Reisner R, Nosslinger T, Gruner H, Nowotny H, Tuchler H, Schlogl E, Pittermann E and Heinz R: Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. Br J Haematol 106: 455-463, 1999.
8. Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E, Prieto F, Granada I, Hernandez JM et al: Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol 108: 346-356, 2000.
9. Fernandez TS, Ornellas MH, de Carralho LO, Tabak D and Abdelhay E: Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leuk Res 24: 839-848, 2000.
10. Kibbelaar RE, Mulder JW, Dreef EJ, Van Kamp H, Fibbe WE, Wessels JW, Beverstock GC, Haul HL and Kluin PM: Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood 82: 904-913, 1993.
11. Jenkins RB, Le Beau MM, Kraker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa R III, Schaid DJ et al: Fluorescence in situ hybridization. A sensitive method for trisomy 8 detection in bone marrow specimens. Blood 79: 3307-3315, 1992.
12. Arif M, Tanaka K, Damodaran C, Asou H, Kyo T, Dohy H and Kamada N: Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization. Leuk Res 20: 709-716, 1996.
13. Flactif M, Lai JL, Preudhomme C and Fenaux P: Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 8: 1012-1018, 1994.
14. Tanaka K, Arif M, Eguchi M, Shintani T, Kumaravel TS, Asaoku H, Kyo T, Dohy H and Kamada N: Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates Cancer Genet Cytogenet 115: 32-38, 1999.
15. Panani A, Ferti A, Avgerinos A and Raptis S: Numerical aberrations of chromosome 8 in gastric cancer detected by fluorescence in situ hybridization. Anticancer Res 24: 155-160, 2004.
16. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Deville P, Ploeg M and Vooijs GP: In Situ hybridization as a tool to study numerical aberrations in solid bladder tumors. Histochemistry 89: 307-316, 1988.
17. Nevill TJ, Fung HC, Shepherd JD et al: Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood 92: 1910-1917, 1998.
18. Romeo M, Chauffaille ML, Silva MRR, Bahia DM and Kerbauy J: Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients, Leuk Res 26: 993-996, 2002.
19. Cherry AM, Brockman SR, Paternoster SF, Hicks GA, Neuberg D, Higgins RR, Bennett JM, Greenberg PL, Miller K, Tallman MS, Rowe J and Dewald GW: Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leuk Res 27: 1085-1090, 2003.
20. Rigolin GM, Bigori R, Milani R, Cavazzini F, Roberti MG, Bardi A, Agostini P et al: Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia 15: 1841-1847, 2001.
21. Ketterling RP, Wyatt WA, VanWier SA, Law M, Hodnefield JM, Hanson CA and Dewald GW: Primary myelodysplastic syndrome with normal cytogenetics: utility of "FISH panel testing" and M-FISH. Leuk Res 26: 235-240, 2002.
22. Trost D, Hidebrandt B, Müller N, Germing V and Royer-Pokora B: Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukemia and normal cytogenetics. Leuk Res 28: 171-174, 2004.